Jiaan Hu
- Geriatrics and Gerontology top 10%
- Frailty in Older Adults 3
-
- Nutrition and Health in Aging 4
- Body Composition Measurement Techniques 3
-
- Cancer Immunotherapy and Biomarkers 3
- Lung Cancer Research Studies 2
- Ear and Head Tumors 2
-
- Lung Cancer Treatments and Mutations 3
-
- PI3K/AKT/mTOR signaling in cancer 2
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Jiaan Hu
16 papers receiving 267 citations
Peers
Comparison fields: 5 of 61
- Geriatrics and Gerontology 39
- Physiology 116
- Oral Surgery 16
- Cancer Research 26
- Oncology 47
Countries citing papers authored by Jiaan Hu
This map shows the geographic impact of Jiaan Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiaan Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiaan Hu more than expected).
Fields of papers citing papers by Jiaan Hu
This network shows the impact of papers produced by Jiaan Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiaan Hu. The network helps show where Jiaan Hu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jiaan Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 3 | |
| 4 | 2021 | 0 | |
| 5 | 2021 | 38 | |
| 6 | 2020 | 86 | |
| 7 | 2020 | 0 | |
| 8 | A detrimental mutation on USP40 unlocks the tumorigenesis in a rare case of lung cancer. | 2019 | 3 |
| 9 | 2019 | 0 | |
| 10 | 2017 | 16 | |
| 11 | 2017 | 11 | |
| 12 | 2017 | 17 | |
| 13 | 2017 | 4 | |
| 14 | 2017 | 5 | |
| 15 | 2017 | 34 | |
| 16 | 2017 | 5 | |
| 17 | 2015 | 15 | |
| 18 | Gefitinib, an EGFR tyrosine kinase inhibitor, activates autophagy through AMPK in human lung cancer cells. | 2014 | 14 |
| 19 | RAF1-MEK1-ERK/AKT axis may confer NSCLC cell lines resistance to erlotinib. | 2013 | 19 |
About Jiaan Hu
Jiaan Hu is a scholar working on Geriatrics and Gerontology, Oncology and Oral Surgery, having authored 19 papers that have together received 273 indexed citations. Recurring topics across this work include Nutrition and Health in Aging (4 papers), Frailty in Older Adults (3 papers), Body Composition Measurement Techniques (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Lung Cancer Treatments and Mutations (3 papers), Lung Cancer Research Studies (2 papers), Ear and Head Tumors (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). The work is most often cited by research in Geriatrics and Gerontology (39 citations), Physiology (116 citations) and Oral Surgery (16 citations). Jiaan Hu has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Jiumei Cao, Yan Ren, Zhihong Xu, Tingting Bai, Fang Fang, Junbiao Hang, Beili Gao, Jie Wu, Ke Yang and Wenwen Sun. Their work appears in journals such as Cancer, Medicine and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.